Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and...
-
Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Kawasaki Disease Market - A Global and Regional Analysis: Focus on Treatment Type and Region, 2025-2035" report has been added to ...
-
Austin, TX, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Automated Insulin Delivery System Market Size, Trends and Insights By Product...
-
Research Triangle Park, N.C. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Worldwide Clinical Trials, Inc. (Worldwide), a global contract research organization (CRO), and Medidata, a Dassault...
-
HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals...
-
Pedro J. Beltran, PhD, a seasoned executive who previously served as Chief Scientific Officer of BBOT, will assume the position of Chief Executive Officer, bringing his extensive drug development...
-
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
AUSTIN, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is...
-
PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of...
-
TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company...
-
KING OF PRUSSIA, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue degraders, today...